Targeted Therapy

Apollo Athenaa Enables 69-Year-Old Patient From Kazakhstan Reclaim Life Through Targeted Therapy And A Single Pill-A-Day

Precision Medicine

Apollo Athenaa Enables 69-Year-Old Patient From Kazakhstan Reclaim Life Through Targeted Therapy And A Single Pill-A-Day

19 Dec 2025

1 min read

FDA Grants Priority Review to ENHERTU® Plus Pertuzumab for First-Line HER2 Positive Metastatic Breast Cancer

Precision Medicine

FDA Grants Priority Review to ENHERTU® Plus Pertuzumab for First-Line HER2 Positive Metastatic Breast Cancer

25 Sep 2025

2 min read

Multiple Myeloma Accounts for 10% of Blood Cancers—But Timely, Targeted Therapy Can Lead to Remission

Multiple Myeloma Accounts for 10% of Blood Cancers—But Timely, Targeted Therapy Can Lead to Remission

19 Aug 2025

2 min read

Read More

Voice Of HealthCare

vohnetwork.com